中国实用内科杂志最新文献

筛选
英文 中文
Laboratory diagnosis of the etiology of viral infectious diseases 病毒性传染病病原学的实验室诊断
中国实用内科杂志 Pub Date : 2020-01-01 DOI: 10.19538/j.nk2020080102
Bo Wang
{"title":"Laboratory diagnosis of the etiology of viral infectious diseases","authors":"Bo Wang","doi":"10.19538/j.nk2020080102","DOIUrl":"https://doi.org/10.19538/j.nk2020080102","url":null,"abstract":"It must grow the awareness that contagious have never been far away from mankind. and the threats have always been next to us. Taking the laboratory detections of severe acute respiratmy syndrome coronavirus 2 (SARS-CoV-Z) as an example, this article mainly introduces the advantages and limitations of the I'eaJ-time fluorescent quantitative PCR and serological antibody detection teehnnlogy that 11an been used for laboratory detections of the etiology of Viral infectious diseases. It is hoped that the intmduetion will be helpful to the clinical diagnosis of viral infectious diseases, espet'ially COVID~19.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68153300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Senile hypopituitarism:characteristics of diagnosis and treatment 老年性垂体功能减退:诊断与治疗特点
中国实用内科杂志 Pub Date : 2011-01-01 DOI: 10.4103/2224-4018.124276
Wang Ying-qia
{"title":"Senile hypopituitarism:characteristics of diagnosis and treatment","authors":"Wang Ying-qia","doi":"10.4103/2224-4018.124276","DOIUrl":"https://doi.org/10.4103/2224-4018.124276","url":null,"abstract":"Hypopituitarism is a clinical syndrome caused by reduced production of adenohypophyseal hormones.Senile hypopituitarism may show a much more complicated picture of clinical manifestations,and a delay in diagnosis and treatment may lead to rapid development of pituitary crisis.Therefore,clinicians should be alerted for senile hypopituitarism.For patients with hyponatremia,hypoglycemia and unexplained coma,an evaluation of pituitary function should be performed.Patients with confirmed hypopituitarism should remain on regular hormone replacement therapy(HRT) and are absolutely not allowed for self-initiated tapering or discontinuation of medications.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70256467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Senile parathyroid dysfunction:characteristics of diagnosis and treatment 老年甲状旁腺功能障碍的诊断与治疗特点
中国实用内科杂志 Pub Date : 2011-01-01 DOI: 10.4103/2224-4018.124280
T. Hu
{"title":"Senile parathyroid dysfunction:characteristics of diagnosis and treatment","authors":"T. Hu","doi":"10.4103/2224-4018.124280","DOIUrl":"https://doi.org/10.4103/2224-4018.124280","url":null,"abstract":"Senile parathyroid dysfunction is mainly seen in primary or secondary hyperparathyroidism(PHPT or SHPT).PHPT in the elderly usually affects in females,with fatigue and osteoporosis as the common symptoms.Screening of blood calcium and further evaluation of parathyroid hormone(PTH) for subjects with blood calcium 2.6mmol/l can be helpful for early identification of patients.For PHPT patients who are indicated for surgery and whose lesion can be well localized,surgical treatment can be more beneficial.SHPT is mainly found in patients with end-stage chronic renal dysfunction necessitating hemodialysis or peritoneal dialysis.For these patients,monitoring of PTH level,early supplement of calcium preparations and use of large-dose calcitriol appears helpful to maintain the blood levels of calcium and PTH.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70256522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Experience and Prognostic Factors with Bortezomib-Combined Regimen in 40 Patients with Multiple Myeloma 硼替佐米联合治疗多发性骨髓瘤40例的临床经验及预后因素分析
中国实用内科杂志 Pub Date : 2008-11-16 DOI: 10.1182/BLOOD.V112.11.5211.5211
Juan Li, Ying Zhao
{"title":"Clinical Experience and Prognostic Factors with Bortezomib-Combined Regimen in 40 Patients with Multiple Myeloma","authors":"Juan Li, Ying Zhao","doi":"10.1182/BLOOD.V112.11.5211.5211","DOIUrl":"https://doi.org/10.1182/BLOOD.V112.11.5211.5211","url":null,"abstract":"To explore the medical effects, prognostic factors relating to the effects and side effects of bortezomib-combined regimen in treatment of multiple myeloma (MM), and evaluate the safety of this regimen in patients with special conditions. Methods: Forty newly diagnosed and relapsed or refractory MM treated with the regimen of combination of bortezomib and dexamethasone in a cycle of 3 weeks. All of the patients received a median of 3 (1–9) cycles of the treatment. Response to bortezomib was evaluated according to the criteria of the European Group for Blood and Marrow Transplantation (EBMT) and adverse events were graded according to the National Cancer Institute Common Toxicity Criteria. Results: Total response rate was 75.0% (30/40), and the rate of CR+nCR was 42.5% (17/40). Eighty percent patients (24/30) showed effects after the first cycle, although the median time of best effect was 2 cycles. Compare to the other types, light-chain type had higher total response rate (100.0% vs. 65.5%, P=0.038)and CR rate (36.4% vs. 6.9%, P=0.039), and also responded earlier with 81.8% (9/11) patients reached the best effect after the first cycle. The factors which showed no relationship to the effects were age ( 65 years, P=0.081), sex (P=0.696), DS staging (P=1.0), ISS staging(P=0.969), newly or retreated (P=0.731), using thalidomide or not(P=0.338), renal function damage or not(P=0.401), PLT level(P=1.0), hypercalcemia or not(P=0.306), Hb level(P=0.70)and the ratio of tumor cells in bone marrow(P=0.693). Grade III~IV adverse effects in this VD regimen was low, including leucocytopenia, thrombocytopenia, diarrh ea and debility, could be relieved by symptomatic treatment or delay the chemotherapy. The rate of infection was high and which was one of the important cause of death. Renal function improvement could be showed in all of the 10 patients who had renal inadequacy, and compared with normal patients, the incidences of side and adverse effects had no statistical differences. Conclusion: The Bortezomib combination regimen has significant effect in MM treatment. It shows more significant in light-chain type patients, and show earlier effect onset. This regimen can be tolerant in most patients, and is also safe in patients with renal inadequacy.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2008-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65808749","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nonalcoholic fatty liver disease and metabolic syndrome 非酒精性脂肪性肝病和代谢综合征
中国实用内科杂志 Pub Date : 2006-03-20 DOI: 10.3760/CMA.J.ISSN.1673-4157.2006.02.001
G. Xi
{"title":"Nonalcoholic fatty liver disease and metabolic syndrome","authors":"G. Xi","doi":"10.3760/CMA.J.ISSN.1673-4157.2006.02.001","DOIUrl":"https://doi.org/10.3760/CMA.J.ISSN.1673-4157.2006.02.001","url":null,"abstract":"Nonalcoholic fatty liver disease(NAFLD)comprises a disease spectrum which includes variable degrees of simple steatosis nonalcoholic steatohepatitis(NASH) and cirrhosis even liver failure and patocellular carcinoma.NAFLD can be considered the hepatic manifestation of the metabolic syndrome and is an independent predictor of type 2 diabetes(T2DM) and cardiovascular disease(CVD).Insulin resistance is the pathogenetic link between the metabolic syndrome and fat accumulation in the liver.Patients with NAFLD are a high risk population of the both of diseases.It's very important significance to early diagnosis and treatment of NAFLD for prevention T2DM and CVD.","PeriodicalId":10176,"journal":{"name":"中国实用内科杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2006-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"70099094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信